Do not prescribe phosphodiesterase-5 inhibitors (PDE5i) in men with erectile dysfunction (ED) without an adequate diagnostic work-up.
Prescribing PDE5i without performing an appropriate diagnostic work-up to detect the ED-associated morbidities represents a missed opportunity. In fact, in ED patients the stratification of cardiovascular risk is simple, non-invasive and can reveal an asymptomatic...
Avoid prescribing mucolytics in children with bronchial asthma.
Inflammation, mucosal edema and mucus hypersecretion increase the narrowing of the bronchial lumen with the formation of mucus plugs that worsen bronchial obstruction in patients with asthma. Studies conducted on the effectiveness of mucolytics to treat asthma and its...
Do not abruptly discontinue/modify Parkinson’s disease therapy.
According to recent evidence, therapy with anti-Parkinsonian drugs is inappropriately discontinued or modified in a large percentage (up to 75%) of patients with Parkinson’s disease who are admitted to emergency or non-neurological hospital wards. This is one of...
Do not delay prescribing levodopa if appropriate, and instead, do not use drugs for the complicated phase of the disease prematurely.
Levodopa prescription as a drug treatment in Parkinson’s disease is often delayed in favour of other drug categories (such as dopamine agonists) due to concerns about the risk of drug-induced motor complications or levodopa toxicity. However, recent evidence has...The campaign DOING MORE DOES NOT MEAN DOING BETTER – CHOOSING WISELY ITALY is promoted by Italy’s Slow Medicine
Recent Comments